GlassScriptPhysician profile
Abby Jo Loch
NPI 1952562456
$1,263.02
in general payments reported to CMS, 2019-2025
24 companies · $90.44 in 2025
The $90.44 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $155 · 2021: $200 · 2022: $325 · 2023: $219 · 2024: $48.86 · 2025: $90.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $345.44 | 2019-2025 | Pediarix, Bexsero, Rotarix |
| Corium, LLC | $190.15 | 2021-2024 | Azstarys |
| Cranial Technologies, INC | $132.25 | 2019-2024 | Doc Band |
| Merck Sharp & Dohme LLC | $119.97 | 2019-2025 | Vaxneuvance, Vaxelis, Enflonsia |
| Sanofi Pasteur INC. | $84.94 | 2019-2025 | |
| Neos Therapeutics, LP | $45.65 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.82 | 2019-2021 | |
| Pfizer INC. | $28.13 | 2022-2023 | |
| Daiichi Sankyo INC. | $24.86 | 2022 | |
| Genzyme Corporation | $23.85 | 2023 | |
| Adlon Therapeutics L.P. | $22.55 | 2020 | |
| Sobi, INC | $20.53 | 2023 | |
| Kaleo, INC. | $19.28 | 2023 | Auvi-Q |
| Astrazeneca Pharmaceuticals LP | $17.80 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.60 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $17.58 | 2022 | |
| Genentech USA, INC. | $17.33 | 2020 | |
| Abbott Laboratories | $16.67 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $15.77 | 2020 | |
| Ucb, INC. | $14.61 | 2022 | |
| Sarepta Therapeutics, INC. | $14.19 | 2021 | |
| Abbvie INC. | $14.09 | 2022 | |
| Biomarin Pharmaceutical INC. | $13.99 | 2025 | Voxzogo 1.2mg |
| Tris Pharma INC | $13.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abby Loch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.